Tags : Developed

Bayer to Fund Five New Startup Companies as Part of

Tuba Khan November 19, 2020

Shots: The funding focuses on fostering the development of a digital health ecosystem in the fields of cardiometabolic and renal diseases, oncology, and women’s health Bayer G4A partnership program offers […]readmore

MedTech

Google Developed AI System for Easy Detection of Last Stage

Vartika Singh October 16, 2018

Shots: The Google AI i.e Lymph Node Assistant (LYNA) was tested to recognize the characteristics of tumors by studying scans from cancer patients in two datasets respectively In the trial […]readmore

Tags : Developed

Bayer to Fund Five New Startup Companies as Part of

Google Developed AI System for Easy Detection of Last Stage

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Developed

Bayer to Fund Five New Startup Companies as Part of

Google Developed AI System for Easy Detection of Last Stage

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company